Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.
about
Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine designComparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in miceNewcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measlesMucosal vaccines against respiratory syncytial virusEnhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs.Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory.Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses.Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins.Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in childrenInterleukin-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses.Lack of interference with immunogenicity of a chimeric alphavirus replicon particle-based influenza vaccine by preexisting antivector immunityAntibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in miceNeed for a safe vaccine against respiratory syncytial virus infection.Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particlesImmunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primatesProtection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin.An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats.Pulmonary V gamma 4+ gamma delta T cells have proinflammatory and antiviral effects in viral lung disease.Sendai virus as a backbone for vaccines against RSV and other human paramyxovirusesLactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunityImmunogenicity of RSV F DNA Vaccine in BALB/c Mice.Targeting RSV with vaccines and small molecule drugs.Immunomodulatory activity of red ginseng against influenza A virus infection.Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease.The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development.Respiratory syncytial virus: current progress in vaccine development.Advances in and the potential of vaccines for respiratory syncytial virus.Self-replicating alphavirus RNA vaccines.CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells iNewcastle disease virus-like particles as a platform for the development of vaccines for human and agricultural pathogensNADPH oxidase limits lipopolysaccharide-induced lung inflammation and injury in mice through reduction-oxidation regulation of NF-κB activity.Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles.Evaluation of Measles Vaccine Virus as a Vector to Deliver Respiratory Syncytial Virus Fusion Protein or Epstein-Barr Virus Glycoprotein gp350.Viral vectors for vaccine applications.Baculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virus.Respiratory syncytial virus vaccine developmentProgress in respiratory virus vaccine development
P2860
Q27021304-118CCE00-6F1E-4952-B2B9-D2B3C92B5BEFQ28752489-E2EDAE01-7E94-4155-9430-4AE7EF4E8E9FQ33558475-D61F26A7-5C54-4C1B-9C87-2F169C4DE619Q33769306-ACEB4FA0-31F9-4E0D-9B09-F9212FFAC2D5Q33837530-0A025005-7479-4284-B99A-91D89C0C0CE8Q33972018-C3CE79BE-DB2E-440E-92A4-DEE43031B0EAQ34059404-54E4BE64-4357-4E3E-A942-F10AF059FE00Q34440116-22CAF1A6-288B-4625-A694-DD876C2A2BA7Q34457791-BA883AA9-EB9C-4B38-AE34-7AF6BD7E5BD4Q34504791-AE4DF340-BA47-478E-B078-6D4B8A261080Q35188476-6CCA8DE2-6C2A-43A5-A7D7-1DE036234D6BQ35595950-49319736-E2A7-43C9-AB48-9D2BD9A30977Q35868095-7DE842AC-7CDA-4F2D-9550-764BBA3608C2Q36086236-EA5346FB-7B26-46F8-A00E-9848672F84AAQ36106575-B7F0DD3C-58B1-4842-856C-3C329B28F98CQ36266896-9FDC136F-2045-43F3-856F-8F1EC81A3206Q36458651-C8F5E34B-34DE-4044-815D-20673D342D1BQ36515541-B0982846-4D14-4752-8900-9D5D38894B88Q36739674-C2E49205-08F6-445B-98C0-2ED02333BEE6Q36949797-C7DE4FA3-4D7D-4115-9B95-C7FC34D00523Q37106159-5C9BF29C-2142-4F52-BBC1-DFF4F66BE8E3Q37118707-39FB1CD0-A171-4FB3-8DB5-1510F182499BQ37215818-ACDD4BC1-B292-45E2-BE95-1B1B2472F38DQ37263840-8E1F5A7A-B45E-4AB6-97B3-EA461C02E628Q37328584-A636E8AF-BBDB-4EB9-9ADF-CFA2A809A00AQ37617698-36C3972A-C4AF-45D1-92E1-FF756206D9C7Q37649439-93322A0F-5743-4BF4-937A-C2C4E83A2682Q38068469-F93966C0-F837-49ED-B629-F921B1ED59E8Q38079432-CA4791DA-BF3D-4B4A-915D-6AF2D0B1BE85Q38130514-D328BCBE-E820-4AA4-9CED-9E0A9852DFDEQ38255634-D911ABCA-8973-49F6-8B61-2CA9CF7C9EB6Q38919640-2031203E-3B10-4A2D-90C6-A873AA8E5D7DQ39780308-2A8F42C6-F443-48F7-8DD2-F7281A014F89Q40021844-4CCD9716-F4CF-4C44-83DC-F1F67DAABB3EQ40065136-3BFE86FC-5AE2-47AC-A7E8-6AA10D48D7ABQ41557807-CFD5035D-CF23-49EB-B8CC-82859D94C145Q41812230-AF685B6C-1234-4A53-87AD-7A87A523E506Q42138587-AF381408-9E54-41B6-8905-94135A81CA77Q56893551-B8604F3E-E5AC-4FC2-85C1-6B1BC9301AD9Q56894869-5309028D-058D-446D-B9C8-3DF6F541EC2A
P2860
Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Venezuelan equine encephalitis ...... onses in mice and cotton rats.
@ast
Venezuelan equine encephalitis ...... onses in mice and cotton rats.
@en
type
label
Venezuelan equine encephalitis ...... onses in mice and cotton rats.
@ast
Venezuelan equine encephalitis ...... onses in mice and cotton rats.
@en
prefLabel
Venezuelan equine encephalitis ...... onses in mice and cotton rats.
@ast
Venezuelan equine encephalitis ...... onses in mice and cotton rats.
@en
P2093
P2860
P356
P1433
P1476
Venezuelan equine encephalitis ...... onses in mice and cotton rats.
@en
P2093
Bryan E Shepherd
Martha L Collier
Nancy L Davis
Robert E Johnston
Thomas J Utley
Vasiliy V Polosukhin
P2860
P304
13710-13722
P356
10.1128/JVI.01351-07
P407
P577
2007-10-10T00:00:00Z